OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	607
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	286
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	257
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	223
DNA Damage and Repair in Thyroid Physiology and Disease	211
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	207
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	165
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	164
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	124
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	121
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity	114
The Molecular Biology of Midgut Neuroendocrine Neoplasms	110
Effects of Maternal Vitamin D Supplementation on Childhood Health	108
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	106
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	104
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	87
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment	86
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	83
The Biology and Clinical Implications of PCSK7	78
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	78
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	71
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity	70
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	67
Estrogen Receptor Signaling in the Immune System	67
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	66

New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	62
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	61
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”	61
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	60
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	58
The Metabolic Role and Therapeutic Potential of the Microbiome	57
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	53
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	53
Imaging of Pheochromocytomas and Paragangliomas	51
Adiponectin and Adiponectin Receptors in Atherosclerosis	51
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	50
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases	47
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	46
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	46
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	45
The Cortisol Awakening Response: Regulation and Functional Significance	45
Brown Adipose Tissue—A Translational Perspective	44
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	43
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	43
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	42
Medullary Thyroid Cancer: Updates and Challenges	41
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities	38
Erratum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	38
Protective Factors and the Pathogenesis of Complications in Diabetes	37
Endocrine Controls of Skin Aging	37
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification	35
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency	35
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	35
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	34
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	34
Retraction and Replacement of: “Effects of Maternal Vitamin D Supplementation on Childhood Health”	34
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors	32
The Role of Iodine for Thyroid Function in Lactating Women and Infants	31
Teprotumumab for the Treatment of Thyroid Eye Disease	31
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	30
Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma	30
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	29
Update on Adipose Tissue and Cancer	28
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	27
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	26
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	25
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	23
Corrigendum to: The Role of Iodine for Thyroid Function in Lactating Women and Infants	22
A Clinical Update on Gestational Diabetes Mellitus	22
Corrigendum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	22
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies	21
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	21
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens	21
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications	20
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	20

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	20
Endocrine Dysfunction in Primary Mitochondrial Diseases	19
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	19
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	19